Navigation Links
Infectious diseases experts applaud bill against 'bad bugs'
Date:9/28/2007

Arlington, VAWith extensively drug-resistant tuberculosis, life-threatening drug-resistant respiratory and skin infections, and other bad bugs routinely making headlines, infectious diseases physicians are applauding Rep. Jim Matheson (D-UT) and Rep. Michael Ferguson (R-NJ) for introducing H.R. 3697, the Strategies To Address Antimicrobial Resistance (STAAR) Act.

The STAAR Act has the potential to save thousands of lives, said Martin J. Blaser, MD, past president of the Infectious Diseases Society of America (IDSA). IDSA strongly supports the STAAR Act and the comprehensive approach that Reps. Matheson and Ferguson are taking to tackle the problem of antimicrobial resistance. Infectious diseases physicians have watched in dismay for years as the antibacterials and other antimicrobials we rely upon to treat our patients have lost their power.

To make matters worse, there are very few new drugs in the pipeline to replace the failing ones, because the pharmaceutical industry now finds developing new antibiotics less appealing than developing drugs for chronic conditions like heart disease. We are in danger of slipping backward to the era before antibiotics, Dr. Blaser added. The STAAR Act gets us back in the fight by enhancing federal leadership, encouraging expert input, and by improving our grasp on resistance and ways to control it.

The issue goes beyond just the pharmaceutical industry, Dr. Blaser said. We are all in this togetherdrug companies, physicians, public health experts, and patients. The STAAR Act makes everyone a partner in the solution.

The bill takes a holistic approach to address inappropriate use, a significant problem that diminishes the effectiveness of antibiotics once they are approved.

It vastly improves the nations capacity to control resistance by establishing a network of experts across the country to conduct regional monitoring of resistant organisms as they occura kind of snapshot to pick up on problems early.

Its a different world versus even five years ago, said Neil Fishman, MD, chair of IDSAs Antimicrobial Resistance Work Group. Multi-drug resistant bugs like Klebsiella and methicillin-resistant Staphylococcus aureus (MRSA) have cropped up and spread practically before anyone has had the chance to examine them under the microscope, much less do anything to stop their spread. The STAAR Act sets up a network to collaborate with the Centers for Disease Control and Prevention on disease surveillance. The network will be CDCs extra eyes and ears looking out for resistant bugs around the nation and finding ways to prevent their spread, Dr. Fishman added.

In a second major activity of the network, researchers also would work with CDC and the National Institutes of Health to find ways to slow the development of resistance. We need to determine the best ways to keep approved antibiotics working longer, said Louis Rice, MD, chair of IDSAs Research on Resistance Work Group. Currently, very little research is focusing on this. The STAAR Act network provides the range of experts we need to study the complex field of drug resistance.

The STAAR Act also creates a board of infectious diseases, public health and veterinary experts to advise the federal government on reducing resistance, and an Office of Antimicrobial Resistance in the Department of Health and Human Services to coordinate, help plan, and guide the governments response to resistance.

IDSA thanks Reps. Matheson and Ferguson for their leadership in introducing this important patient safety and public health bill, and encourages Congress to pass it quickly.

IDSA has been warning that the bad bugs are getting ahead of us, Dr. Blaser said. We are glad to see Congress is listening. But we need this legislation to pass soon. It takes years to develop, strengthen, and implement new control strategies. These bad bugs are not waiting.


'/>"/>

Contact: Steve Baragona
sbaragona@idsociety.org
703-299-0412
Infectious Diseases Society of America
Source:Eurekalert

Related medicine news :

1. Transmission Of Infectious Disease On Planes Analyzed
2. Sex Played A Vital Role For Evolution Of Infectious Diseases
3. Systemic Corticosteroid Therapy can be used for treating all types of Infectious Mononucleosis
4. Infectious Diseases of the Wild to grow
5. Infectious Diseases Reduced in China
6. HIV Becomes More Infectious Due To Human Immune-system Protein
7. G8 Leaders Vows to Combat Infectious Diseases Worldwide
8. Multiple infectious disease strains can coexist
9. Experts Are Optimistic Of Making Waterborne Infectious Diseases A Thing Of Past
10. Canada Funds State-of-art Infectious Disease Lab in Kenya
11. Europe Faces Threat Of Rise In Infectious Diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... 2016 , ... Those who have experienced traumatic events may suffer from a ... such as drug or alcohol abuse, as a coping mechanism. To avoid this pain ... following a traumatic event. , Trauma sufferers tend to feel a range of emotions, ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited ... To Recovery® program to drive cancer patients to and from their cancer treatments. ... highest quality of life and ongoing independence. Getting to and from medical treatments ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its ... Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding ... Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, we ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, ... economy by obtaining investment capital for emerging technology companies. SCP has delivered ... already resulted in more than a million dollars of capital investment for five ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016  MedSource announced today that it has ... solution of choice.  This latest decision demonstrates MedSource,s ... their clients by offering a state-of-the-art electronic data ... nowEDC as the EDC platform of choice in ... "nowEDC has long been a preferred EDC platform ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... June 23, 2016 , , ... July 7, 2016 , , , , LOCATION: , , ... , , , EXPERT PANELISTS:  , , , Frost & ... Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, ... The global pharmaceutical industry is witnessing an exceptional era. Several new ...
Breaking Medicine Technology: